二仙汤辅助治疗绝经后女性高血压的临床效果及对雌激素和Kupperman评分的影响

摘要
图/表
参考文献(20)
相关文章 (15)

全文: PDF (607 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨二仙汤辅助治疗绝经后女性高血压的临床效果及对雌激素和Kupperman评分的影响。方法采用随机对照的临床研究方法，选取2016年6月～2018年12月就诊于浙江省温州市中医院门诊和病房的绝经后女性高血压患者68例。根据随机数字表法分为两组，对照组（34例）采用贝那普利治疗，干预组（34例）在贝那普利治疗的基础上加用二仙汤。观察8周，记录两组治疗前后血压、雌激素水平、Kupperman评分，比较两组疗效。结果治疗后，两组收缩压和舒张压均较治疗前降低，且干预组显著低于对照组，差异有统计学意义（P ＜ 0.05）。治疗后，干预组的雌二醇水平均高于治疗前及对照组，差异有统计学意义（P ＜ 0.05）；治疗后，干预组的卵泡刺激素水平均低于治疗前及对照组，差异有统计学意义（P ＜ 0.05）。治疗后，两组Kupperman评分均较治疗前降低，且干预组显著低于对照组，差异有统计学意义（P ＜ 0.05）。干预组治疗后总有效率高于对照组，差异有统计学意义（P ＜ 0.05）。结论二仙汤在贝那普利治疗的基础上能进一步降低绝经后女性高血压患者的收缩压和舒张压，也能调节雌激素水平，改善Kupperman评分。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	项晓觉孙腾飞张云霞吴静

关键词 ：二仙汤, 绝经, 高血压, 雌激素, Kupperman评分

Abstract：Objective To investigate clinical effect of Erxian Decoction in adjuvant treatment of postmenopausal women with hypertension and its effect on estrogen and Kupperman score. Methods Randomized controlled clinical trial method was used, 68 postmenopausal women with hypertension treated in outpatient and ward of Wenzhou Traditional Chinese Medicine Hospital from June 2016 to December 2018 were selected and divided into two groups with random number table, control group (34 cases) was treated with Benazepril, and intervention group (34 cases) was treated with Erxian Decoction on the basis of Benazepril. Observed for 8 weeks, blood pressure, estrogen levels, Kupperman scores of two groups before and after treatment were recorded and curative effect between two groups was compared. Results After treatment, systolic and diastolic blood pressure levels of two groups were lower than those before treatment, intervention group was significantly lower than control group, the differences were statistically significant (P < 0.05). After treatment, estradiol level in intervention group was higher than that before treatment and in control group, the differences were statistically significant (P < 0.05). After treatment, level of FSH in intervention group was lower than that before treatment and in control group, the difference was statistically significant (P < 0.05). After treatment, Kupperman scores of two groups were lower than those before treatment, and intervention group was significantly lower than control group, the differences were statistically significant (P < 0.05). Total effective rate of intervention group was higher than that of control group, the difference was statistically significant (P < 0.05). Conclusion Erxian Decoction can further reduce systolic and diastolic blood pressure of postmenopausal women with hypertension on the basis of Benazepril treatment. It can also regulate estrogen level and improve Kupperman score.

Key words： Erxian Decoction Menopause Hypertension Estrogen Kupperman score

基金资助:浙江省温州市科技计划项目（Y20160214）。

作者简介: 项晓觉（1985.11-），男，硕士；研究方向：心血管疾病的中西医结合治疗。

引用本文:

项晓觉孙腾飞张云霞吴静. 二仙汤辅助治疗绝经后女性高血压的临床效果及对雌激素和Kupperman评分的影响[J]. 中国医药导报, 2020, 17(8): 170-173.
XIANG Xiaojue SUN Tengfei ZHANG Yunxia WU Jing. Clinical effect of Erxian Decoction in adjuvant treatment of postmenopausal women with hypertension and its effect on estrogen and Kupperman score. 中国医药导报, 2020, 17(8): 170-173.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2020/V17/I8/170

[1] 王予，徐沛瑶，朱敏.高血压患者住院费用及其影响因素研究[J].中国卫生统计，2019，36（4）：574-577.
[2] Lawes CM，Hoorn SV，Law MR，et al. Blood pressure and the global burden of disease 2000.Part 1：estimates of blood pressure levels [J]. J Hypertens，2006，24（3）：413-422.
[3] Muka T，Oliver-Williams C，Kunutsor S，et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes，intermediate vascular traits，and all-cause mortality：a systematic review and meta-analysis [J]. Jama Cardiol，2016，1（7）：767.
[4] Appiah D，Schreiner PJ，Demerath EW，et al. Association of age at menopause with incident heart failure：a prospective cohort study and meta-analysis [J]. JAHA，2016，5（8）：e003769.
[5] Collins P，Rosano G，Casey C，et al. Management of cardiovascular risk in the perimenopausal women：a consensus statement of European cardiologists and gynecologists [J]. Kardiol Pol，2007 65（11）：508-526.
[6] Lobo RA，Pickar JH，Stevenson JC，et al. Back to the future：hormone replacement therapy as part of a prevention strategy for women at the onset of menopause [J]. Atherosclerosis，2016，254：282-290.
[7] 刘力生.中国高血压防治指南2010[J].中华高血压杂志，2011，19（8）：701-708.
[8] 郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：73-77.
[9] 上海中医学院中医基础理论教研组.中医方剂临床手册[M].上海：上海人民出版社，1973：113.
[10] 曹泽毅.中华妇产科学（下册）[M].北京：人民卫生出版社，2005：2537-2589.
[11] 张行，杨传华，任晨晨.杨传华应用二仙汤加减治疗围绝经期高血压病经验总结[J].亚太传统医药，2018，14（2）：146-147.
[12] 刘俊梅.二仙汤加减治疗围绝经期高血压86例[J].云南中医中药杂志，2017，38（5）：51-52.
[13] 徐明丽.分析探讨二仙汤加减联合贝那普利治疗更年期女性高血压的临床疗效[J].中医临床研究，2015，7（17）：53-54.
[14] 米加，彭敏.新加二仙汤治疗老年高血压伴焦虑状态临床研究[J].山东中医杂志，2017，36（9）：747-750.
[15] 张亮，陈坤，薛金贵，等.加减二仙汤治疗阴虚阳亢型围绝经期高血压病的临床观察[J].上海中医药大学学报，2014，28（4）：38-41.
[16] Khalil RA. Estrogen，vascular estrogen receptor and hormone therapy in postmenopausal vascular disease [J]. Bio-chem Pharmacol，2013，12（15）：1627-1642.
[17] 杨蕾，王继峰，牛建昭，等.二仙汤及其拆方治疗卵巢早衰的实验研究进展[J].环球中医药，2017，10（5）：626-630.
[18] 宋维华.二仙汤加味对更年期患者血清E2、TPH2及5-HT的干预作用研究[J].云南中医中药杂志，2017，38（8）：40-42.
[19] 张晓燕.二仙汤加味治疗更年期综合征疗效分析[J].实用中医药杂志，2017，33（12）：1362-1364.
[20] 康建颖，陆月红.二仙汤治疗围绝经期综合症患者的临床疗效及对性激素的影响[J].健康研究，2017，37（3）：321-323.